Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00330187 · ClinicalTrials.gov registry record · Phase 2
Combined Pharmaco/Behavior Therapy in Adolescent Smokers
A Phase 2 study, sponsored by Medical University of South Carolina.
- Completed
- Registry status
- Phase 2
- Development phase
- 134
- Enrollment target
NCT00330187 is a Phase 2 study that has completed, run by Medical University of South Carolina. The registered enrollment target is 134 participants.
The verdict
NCT00330187, a Phase 2 study, has completed, sponsored by Medical University of South Carolina.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 134 participants
- Enrollment target
Study Summary
In the current proposal, we intend to study the efficacy of bupropion SR with or without combined contingency management (CM) among adolescent cigarette smokers. The proposed study will test not only medication (bupropion SR), but also combination of medication and CM in potentially improving smoking cessation outcomes AND retention of adolescent smokers in the study. Hypothesis to be tested: Bupropion SR treatment will increase abstinence from cigarette smoking (as measured by urine cotinine and continuous abstinence) in adolescent smokers as compared to treatment with placebo only. Hypothesis to be tested: Adolescent smokers treated with combined bupropion SR + contingency management (CM) treatment will have increased retention and increased abstinence rates when compared to bupropion SR alone or CM + placebo treated groups (as measured by decreased drop-out of participants, urine cotinine and continuous abstinence). Hypothesis to be tested: CM will increase the abstinence from cigarette smoking (as measured by urine cotinine and continuous abstinence) in adolescent smokers as compared to treatment with placebo only.
Interventions
- OTHER Placebo
- BEHAVIORAL Contingency Management
- DRUG Bupropion SR
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 134 participants |
| Start Date | 2004-03 |
| Est. Completion | 2009-07 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00330187
The ClinicalTrials.gov registry entry for NCT00330187 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 134 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medical University of South Carolina, which has 755 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT00330187 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00330187 about?
NCT00330187 is a clinical study titled "Combined Pharmaco/Behavior Therapy in Adolescent Smokers". In the current proposal, we intend to study the efficacy of bupropion SR with or without combined contingency management (CM) among adolescent cigarette smokers. The proposed study will test not only medication (bupropion SR), but also combination of medication and CM in potentially improving smokin...
What is the current status of trial NCT00330187?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 134 participants. The study started on 2004-03. Estimated completion is 2009-07.
What interventions are being tested in trial NCT00330187?
The interventions under investigation include: Placebo (OTHER), Contingency Management (BEHAVIORAL), Bupropion SR (DRUG).
Who is sponsoring clinical trial NCT00330187?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.